ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

CD8+ T-Cell Epitope Variations Suggest a Potential Antigen HLA-A2 Binding Deficiency for Spike Protein of SARS-CoV-2

Qiu, Congling; Xiao, Chanchan; Wang, Zhigang; Zhu, Guodong; Mao, Lipeng; Chen, Xiongfei; Gao, Lijuan; Deng, Jieping; Su, Jun; Su, Huanxing; Fang, Evandro Fei; Zhang, Zhang-Jin; Zhang, Jikai; Xie, Caojun; Yuan, Jun; Luo, Oscar Junhong; Huang, Lian; Wang, Pengcheng*; Chen, Guobing*1
Frontiers in Immunology2022-1-18DOI: 10.3389/fimmu.2021.764949
11被引4阅读
引用收藏
分享

摘要

We identified SARS-CoV-2 specific antigen epitopes by HLA-A2 binding affinity analysis and characterized their ability to activate T cells. As the pandemic continues, variations in SARS-CoV-2 virus strains have been found in many countries. In this study, we directly assess the immune response to SARS-CoV-2 epitope variants. We first predicted potential HLA-A*02:01-restricted CD8(+) T-cell epitopes of SARS-CoV-2. Using the T2 cell model, HLA-A*02:01-restricted T-cell epitopes were screened for their binding affinity and ability to activate T cells. Subsequently, we examined the identified epitope variations and analyzed their impact on immune response. Here, we identified specific HLA-A2-restricted T-cell epitopes in the spike protein of SARS-CoV-2. Seven epitope peptides were confirmed to bind with HLA-A*02:01 and potentially be presented by antigen-presenting cells to induce host immune responses. Tetramers containing these peptides could interact with specific CD8(+) T cells from convalescent COVID-19 patients, and one dominant epitope (n-Sp1) was defined. These epitopes could activate and generate epitope-specific T cells in vitro, and those activated T cells showed cytolytic activity toward target cells. Meanwhile, n-Sp1 epitope variant 5L>F significantly decreased the proportion of specific T-cell activation; n-Sp1 epitope 8L>V variant showed significantly reduced binding to HLA-A*02:01 and decreased proportion of n-Sp1-specific CD8(+) T cell, which potentially contributes to the immune escape of SARS-CoV-2. Our data indicate that the variation of a dominant epitope will cause the deficiency of HLA-A*02:01 binding and T-cell activation, which subsequently requires the formation of a new CD8(+) T-cell immune response in COVID-19 patients.

学科与关键词

关键词
SARS-CoV-2CD8(+) T-cell epitopespike proteinvariationsantigen presentation deficiency
相关
加载中…
  • Identification of HLA-A2 restricted CD8+ T cell epitopes in SARS-CoV-2 structural proteins
    Deng, Jieping; Pan, Junping; Qiu, Minghui; Mao, Lipeng; Wang, Zhigang; Zhu, Guodong; Gao, Lijuan; Su, Jun; Hu, Yutian; Luo, Oscar Junhong; Chen, Guobing*; Wang, Pengcheng*Journal of Leukocyte Biology, 2021, 110(6): 1171-1180.被引 9
  • SARS-CoV-2 variant B.1.1.7 caused HLA-A2+ CD8+ T cell epitope mutations for impaired cellular immune response
    Xiao, Chanchan; Mao, Lipeng; Wang, Zhigang; Gao, Lijuan; Zhu, Guodong; Su, Jun; Chen, Xiongfei; Yuan, Jun; Hu, Yutian; Yin, Zhinan; Xie, Jun; Ji, Weiqing; Niu, Haitao; Gao, Feng; Luo, Oscar Junhong; Xiao, Lianbo*; Wang, Pengcheng*; Chen, Guobing*iScience, 2022, 25(3): 103934.被引 7
  • SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity
    Motozono, Chihiro; Toyoda, Mako; Zahradnik, Jiri; Saito, Akatsuki; Nasser, Hesham; Tan, Toong Seng; Ngare, Isaac; Kimura, Izumi; Uriu, Keiya; Kosugi, Yusuke; Yue, Yuan; Shimizu, Ryo; Ito, Jumpei; Torii, Shiho; Yonekawa, Akiko; Shimono, Nobuyuki; Nagasaki, Yoji; Minami, Rumi; Toya, Takashi; Sekiya, Noritaka; Fukuhara, Takasuke; Matsuura, Yoshiharu; Schreiber, Gideon; Ikeda, Terumasa*; Nakagawa, So*; Ueno, Takamasa*; Sato, Kei*Cell Host and Microbe, 2021, 29(7): 1124-+.被引 362
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2022-01-18
卷期
第 12 卷
页码
764949
DOI
10.3389/fimmu.2021.764949
语言
ENGLISH
期刊等级
2区
成果收录
SCIE

作者

  • Q

    Qiu, Congling (第一作者)

  • X

    Xiao, Chanchan

查看全部 19 位作者收起作者
  • W

    Wang, Zhigang

  • Z

    Zhu, Guodong

    1

  • M

    Mao, Lipeng

  • C

    Chen, Xiongfei

    guangzhou ctr dis control & prevent

  • G

    Gao, Lijuan

  • D

    Deng, Jieping

  • S

    Su, Jun

  • S

    Su, Huanxing

  • F

    Fang, Evandro Fei

  • Z

    Zhang, Zhang-Jin

    univ hong kong

  • Z

    Zhang, Jikai

  • X

    Xie, Caojun

    guangzhou ctr dis control & prevent

  • Y

    Yuan, Jun

    guangzhou ctr dis control & prevent

  • L

    Luo, Oscar Junhong

  • H

    Huang, Lian

  • W

    Wang, Pengcheng (通讯)

  • C

    Chen, Guobing (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417